Unichem Laboratories Ltd. — Board/Management Information 2024

Sep 23, 2024

23[rd] September 2024

==> picture [190 x 43] intentionally omitted <==

Ref.: ULL/SEC/Compliance/2024-25

BSE Ltd National Stock Exchange of India Limited 1st Floor, New Trading Ring Exchange Plaza, Rotunda Building, P J Tower Bandra Kurla Complex Dalal Street, Fort, MUMBAI – 400 001 Bandra East, MUMBAI – 400 051

BSE Scrip Code – 506690

NSE Symbol – UNICHEMLAB

Dear Sir/Madam,

Sub: Notice of Board Meeting & Trading window closure

Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in shares of the Company will be closed for Designated Persons, Directors, Insiders and their Immediate Relatives from Monday, 23[rd] September 2024 in view of the meeting of the Board of Directors of the Company scheduled to be held on Monday, 30[th] September 2024 to consider, inter-alia, integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company’s holding company, Ipca Laboratories Limited) into Unichem Pharmaceuticals (USA) Inc. (company’s wholly owned subsidiary) so as to consolidate all the Ipca Group’s USA generics formulations business under one entity.

The window closure will continue from 1[st] October 2024 till 48 hours after declaration of financial results of the Company for the quarter and half year ended 30[th] September 2024 for Designated Persons, Directors, Insiders and their Immediate Relatives.

Please take the above on record.

For UNICHEM LABORATORIES LIMITED

PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2024.09.23 08:45:57 +05'30' PRADEEP BHANDARI Head – Legal & Company Secretary

==> picture [531 x 62] intentionally omitted <==